AbbVie: FDA Approves Emblaveo - Metronidazole Combination For Complicated Intra-Abdominal Infections
AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...
Monthly Prescribing Reference6mon
Metronidazole Tablets
Metronidazole exerts antibacterial effects in an anaerobic environment against most obligate anaerobes. Once metronidazole enters the organism by passive diffusion and activated in the cytoplasm ...
Medscape2d
Clinical Management of Intra-Amniotic Infection and Chorioamnionitis: A Review of the Literature
Metronidazole (Flagyl) 500 mg orally twice a day for 7 days Metronidazole (Flagyl) 250 mg orally three times a day for 7 days Clindamycin 300 mg orally twice a day for 7 days Metronidazole (Flagyl ...
Medscape22d
Current and Future Treatment Modalities for Clostridium difficile-Associated Disease
A prospective, randomized, controlled clinical trial compared metronidazole 250 mg orally four times daily with vancomycin 500 mg orally four times daily, each for 10-day courses. [43] Fewer ...
Monthly Prescribing Reference6mon
Metronidazole Injection
Metronidazole 500mg/100mL; soln for IV infusion; contains sodium. Metronidazole exerts antibacterial effects in an anaerobic environment against most obligate anaerobes. Once metronidazole enters ...